TY  - GEN
AU  - Chopra,Arvind
AU  - Chandrashekara,S
AU  - Iyer,Rajgopalan
AU  - Rajasekhar,Liza
AU  - Shetty,Naresh
AU  - Veeravalli,Sarathchandra Mouli
AU  - Ghosh,Alakendu
AU  - Merchant,Mrugank
AU  - Oak,Jyotsna
AU  - Londhey,Vikram
AU  - Barve,Abhijit
AU  - Ramakrishnan,M S
AU  - Montero,Enrique
TI  - Itolizumab in combination with methotrexate modulates active rheumatoid arthritis: safety and efficacy from a phase 2, randomized, open-label, parallel-group, dose-ranging study
SN  - 1434-9949
PY  - 2017///0116
KW  - Administration, Oral
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antirheumatic Agents
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Drug Therapy, Combination
KW  - methods
KW  - Female
KW  - Humans
KW  - India
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Patient Safety
KW  - Reproducibility of Results
KW  - Rheumatology
KW  - Surveys and Questionnaires
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s10067-015-2988-9
ER  -